Safety and Efficacy of AG-221, a Potent Inhibitor of Mutant IDH2 That Promotes Differentiation of Myeloid Cells in Patients with Advanced Hematologic Malignancies: Results of a Phase 1/2 Trial Stein, E. M., DiNardo, C., Altman, J. K., Collins, R., DeAngelo, D. J., Kantarjian, H. M., Sekeres, M. A., Fathi, A. T., Flinn, I. W., Frankel, A. E., Levine, R. L., Medeiros, B. C., Patel, M. R., Pollyea, D., Roboz, G. J., Stone, R. M., Swords, R. T., Tallman, M. S., Yen, K., Attar, E. C., Xu, Q., Tosolini, A., Mei, J. M., Thakurta, A., Knight, R. D., De Botton, S. AMER SOC HEMATOLOGY. 2015

View details for Web of Science ID 000368019001075